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The orphan receptor Gpr83 regulates systemic
energy metabolism via ghrelin-dependent and
ghrelin-independent mechanisms
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The G protein-coupled receptor 83 (Gpr83) is widely expressed in brain regions regulating
energy metabolism. Here we report that hypothalamic expression of Gpr83 is regulated in
response to nutrient availability and is decreased in obese mice compared with lean mice. In
the arcuate nucleus, Gpr83 colocalizes with the ghrelin receptor (Ghsr1a) and the agouti-
related protein. In vitro analyses show heterodimerization of Gpr83 with Ghsr1a diminishes
activation of Ghsr1a by acyl-ghrelin. The orexigenic and adipogenic effect of ghrelin is
accordingly potentiated in Gpr83-deficient mice. Interestingly, Gpr83 knock-out mice have
normal body weight and glucose tolerance when fed a regular chow diet, but are protected
from obesity and glucose intolerance when challenged with a high-fat diet, despite hyper-
phagia and increased hypothalamic expression of agouti-related protein, Npy, Hcrt and
Ghsr1a. Together, our data suggest that Gpr83 modulates ghrelin action but also indicate that
Gpr83 regulates systemic metabolism through other ghrelin-independent pathways.
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T
he murine G protein-coupled receptor (GPCR) 83 (Gpr83)
is an orphan receptor belonging to the rhodopsin-like or
family A of GPCRs1. This family is by far the largest
subfamily of GPCRs and includes several receptors implicated in
the regulation of systemic metabolism, such as the ghrelin
receptor (Ghsr1a)2,3 and the orexin receptors 1 and 2 (Ox1r and
Ox2r)4. Gpr83 was originally identified as a glucocorticoid-
induced transcript in a murine T cell line and, therefore,
was referred to as glucocorticoid-induced receptor5. Induction
of Gpr83 mRNA expression following dexamethasone6 or
amphetamine7 treatment suggests a possible role in the regu-
lation of the hypothalamus–pituitary–adrenal axis. This
possibility is further supported by the observation that Gpr83 is
expressed in hypothalamic nuclei that govern energy balance,
such as the arcuate nucleus (ARC), the paraventricular nucleus
and the lateral hypothalamic area6,8–10. As Gpr83 is expressed in
hypothalamic nuclei relevant for energy metabolism control and
as a potential modulator of the hypothalamus–pituitary–adrenal
axis might also be relevant for systems metabolism, we
hypothesized that Gpr83 might have a role in the central
regulation of energy metabolism.
To test this hypothesis, we analysed the expression of Gpr83 in
the mouse hypothalamus and observed that its expression is
regulated by nutrient availability. In the ARC, we further find
Gpr83 being colocalized with both the ghrelin receptor (Ghsr1a)
and the agouti-related protein (AgRP), and in vitro analysis
in HEK293 and mouse hypothalamic N41 cells show hetero-
dimerization of Gpr83 with Ghsr1a that reduces ghrelin receptor
activity. In line with this observation, the effects of ghrelin
treatment on food intake and adiposity are enhanced in Gpr83
knock-out (Gpr83 ko) mice, thus supporting a functional
interaction between Gpr83 and Ghsr1a in vivo. However, Gpr83
ko mice are also protected from obesity and glucose intolerance
following exposure to high-fat diet (HFD), despite relative
hyperphagia and increased hypothalamic expression of AgRP,
Npy, Hcrt and Ghsr1a. Taken together, these data suggest that
Gpr83 has multiple ghrelin-dependent and ghrelin-independent
roles in the regulation of systemic energy metabolism.
Results
Colocalization of Gpr83 with Ghsr1a and AgRP. Gene
expression profiling in C57BL/6 mice confirmed that Gpr83 is
predominantly expressed in the brain, with moderate expression
in the hypothalamus. In line with previous studies7, no expression
was observed in peripheral tissues, such as the liver, muscle, heart,
testis, as well as the white and brown adipose tissue (Fig. 1a).
Of appreciable note, analysis of hypothalamic Gpr83 expression
revealed a decrease in mice with diet-induced obesity as
compared with age-matched, lean controls (Fig. 1b). Further-
more, fasting of lean mice for 12, 24 or 36 h resulted in a time-
dependent decrease in the hypothalamic expression of Gpr83
(Fig. 1c). Refeeding with either a HFD or a fat-free diet for 6 h
caused a subsequent increase in hypothalamic Gpr83 mRNA
expression (Fig. 1c). In situ hybridization histochemistry in
combination with immunohistochemistry revealed a broad
abundance of Gpr83 in the ARC. In particular, we found
Gpr83 expressed in specific subsets of ARC neurons that express
Ghsr1a (Fig. 2a–c) and AgRP (Fig. 2d,f).
Heterodimerization of Gpr83 and Ghsr1a. To determine
whether Gpr83 influences ghrelin–Ghsr1a signalling, we next
examined whether both receptors interact in vitro. Both sandwich
enzyme-linked immunosorbent assay (ELISA) and a yellow
fluorescent protein (YFP)-based protein complementation assay
(YFP-PCA) revealed heterodimerization of Gpr83 and Ghsr1a
(Fig. 3a,b). Furthermore, cotransfection of Ghsr1a and Gpr83 in
HEK293 cells led to a 43% reduction in ghrelin-stimulated
Ghsr1a activity compared with control cells cotransfected with
Ghsr1a and the rat muscarinic acetylcholine receptor M3 (rM3R)
(Fig. 3c). Of appreciable note, this effect was not due to changes
in the cell surface or total Ghsr1a expression (Fig. 3d,e), and
Gpr83 activity was not influenced by treatment with acyl ghrelin,
des-acyl ghrelin or obestatin (Supplementary Fig. S1A).
Furthermore, heterodimerization of Gpr83 and Ghsr1a was also
observed in mouse hypothalamic N41 cells cotransfected with
Ghsr1a and Gpr83 (Supplementary Fig. S1B). Together, these
data indicate that Gpr83–Ghsr1a heterodimerization reduces
activation of Ghsr1a by ghrelin, thus supporting a possible role
for Gpr83 in the regulation of energy homeostasis by reducing the
ability of ghrelin to activate its only known endogenous receptor.
Metabolic phenotype of chow-fed Gpr83 ko mice. To determine
whether Gpr83 has a role in regulating systemic metabolism
in vivo, we next assessed the metabolic phenotype of Gpr83-
deficient (Gpr83 ko) mice. These mice had normal body weight,
food intake, glucose tolerance and insulin sensitivity when fed a
regular chow diet (Fig. 4), whereas free-fatty acids (FFA) were
increased under the same conditions (Table 1). Compared with
wild-type (wt) control mice, body fat mass (Fig. 4b) and plasma






















































































































Figure 1 | Gene expression profiling of Gpr83 in C57BL/6 mice. Expression pattern of Gpr83 in different brain areas, as well as in peripheral tissues (a).
Hypothalamic expression of Gpr83 in diet-induced obese (DIO) compared with lean mice (N¼ 6–8 mice per group) (b). Hypothalamic expression of Gpr83
in response to fasting for 12, 24 or 36 h, and after refeeding for 6 h with either a high-fat diet (HFD) or a fat-free diet (FFD, N¼6–8 mice per group) (c).
*Po0.05, **Po0.01, ***Po0.001 based on unpaired two-tailed Student’s t-test (b) or one-way analysis of variance followed by Newman-Keuls multiple
comparison test (c). Data represent means±s.e.m. Ab lib, ad libitum.
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Figure 2 | Gpr83 abundance in the arcuate nucleus of the hypothalamus. Dual labelling by in situ hybridization histochemistry for Gpr83 and
immunohistochemistry for Ghsr and AgRP. Gpr83 locates in ghrelin receptor expressing neurons (a–c) or AgRP neurons (d–f) in the arcuate nucleus of the


























































































































































































































































Figure 3 | mGpr83 forms heterodimers with mGhsr and modifies its signalling properties. Cells were transiently cotransfected with equal amounts of
differentially tagged Gpr83 and Ghsr, respectively. Sandwich ELISA studies in COS-7 cells, expressed as % absorption (492 nm/620nm) relative to positive
control (NHA-Mc3rþGhsr-Flag) and mock (NHA-Ghsr) (a). YFP-based protein complementation assay in HEK293 cells, expressed as % fluorescent cells
to positive control (Mc3r-YFP1þGhsr-YFP2) (b) and functional characterization of the Ghsr/Gpr83 heterodimer in HEK293 (c). Measurement of inositol-3
phosphate (IP3) following stimulation with 1,000 nM ghrelin was carried out 48 h after transfection. (d) HA-tags of receptors on the cell surface in
comparison with untagged rM3R as negative control. (e) HA- and Flag-double tagged receptors expressed as fold over the rM3R negative control
(e,d). Data were assessed from a minimum of three independent experiments (a–e), each performed at least in triplicates (a,c–e). Cntrl, control; rM3R,
rat muscarinic acetylcholine receptor M3. Data represent mean±s.e.m. ***Po0.001 based on one-way analysis of variance followed by Bonferroni’s
post-hoc test.
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notable difference in lean tissue mass (Fig. 4c). These data suggest
that under normal feeding conditions, Gpr83 may be involved in
regulating lipolysis. No difference between chow-fed mice was
observed in basal plasma levels of insulin, insulin-like growth
factor 1, growth hormone (GH), cholesterol or triglycerides
(Table 1).
Acute and chronic ghrelin treatment in Gpr83 ko mice. To test
the hypothesis that Gpr83 deficiency in adult mice would enhance
ghrelin action through uninhibited ghrelin-receptor signalling, we
measured acute food intake in chow-fed Gpr83 ko and wt mice
following a single intraperitoneal injection of ghrelin
(4.8mmol kg 1) or saline. Following ghrelin treatment, acute
food intake was significantly higher in Gpr83 ko mice compared
with that of wt controls (Fig. 5a), although there was a similar
response in ghrelin-induced GH secretion (Fig. 5b). Of
appreciable note, twice-daily subcutaneous ghrelin treatment
(2.4mmol kg 1 per day) of HFD fed Gpr83 ko and wt mice for 6
days revealed a greater increase in food intake in the Gpr83 ko
mice (Fig. 5c,d).
As the effects of ghrelin on appetite and energy homeostasis are
mediated by the central nervous system, we next implanted
osmotic minipumps to allow chronic intracerebroventricular (icv)
infusion of ghrelin (5 nmol per day) into chow-fed Gpr83 ko mice
and matched wt controls. Under these conditions, ghrelin
treatment led to a greater increase in body weight (Fig. 6a,b),
food intake (Fig. 6c,d) and fat mass (Fig. 6e) in Gpr83 ko mice as
compared with that of wt controls. Consistent with the greater
increase in fat mass following ghrelin treatment, plasma leptin
was also increased significantly in Gpr83 ko but not in wt mice,
whereas FFA levels were decreased (Table 1). Taken together,
these data suggest that Gpr83 expression in the central nervous
system reduces the response to ghrelin in vivo.
Gpr83 ko mice are protected from diet-induced obesity. As
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Figure 4 | Metabolic phenotype of chow-fed global Gpr83 ko mice. Body weight (a), body composition (b,c), food intake (d), as well as glucose tolerance
(ipGTT, 1.5 g glucose per g body weight) (e) and insulin sensitivity (ipITT) (f) of Gpr83 ko (N¼ 7) and wt (N¼ 9) mice fed with a regular chow diet.
*Po0.05 based on unpaired two-sided Student’s t-test. Data represent means±s.e.m.
Table 1 | Plasma analysis of chow-fed Gpr83 ko and wt mice treated chronically icv with either ghrelin or saline.
wt ko wt vs. ko
Saline Ghrelin P-value Saline Ghrelin P-value Saline
Leptin (ngml 1) 2.62±0.75 2.81±0.28 NS 1.03±0.16 3.58±0.63 o0.001 o0.05
Insulin (ngml 1) 1.20±0.12 2.54±0.40 o0.05 1.04±0.10 2.81±0.43 o0.001 NS
FFA (mmol l 1) 0.50±0.03 0.49±0.03 NS 0.63±0.04 0.49±0.04 o0.05 o0.05
TAG (mgdl 1) 45.81±4.71 52.93±6.06 NS 57.42±6.34 69.43±5.92 NS NS
Cholesterol (mg dl 1) 69.09±5.57 72.29±3.87 NS 73.31±4.56 77.88±4.47 NS NS
IGF-1 (mgml 1) 0.26±0.03 0.34±0.03 NS 0.27±0.03 0.28±0.03 NS NS
GH (AUC) 2.62±0.81 1.61±0.47 NS 1.74±0.54 1.38±0.30 NS NS
AUC, area under curve; FFA, free-fatty acids; GH, growth hormone; icv, intracerebroventricular; IGF-1, insulin-like growth factor-1; ko, knock-out; TAG, Triglycerides; wt, wild-type.
Gpr83 ko and wt mice were treated chronically (icv) for 7 days with either ghrelin (5 nmol, 0.5ml h 1) or saline (N¼6–7 mice per group). Two hours before sample collection, mice were given a single
subcutaneous injection of either ghrelin (200 mg) or saline. For the measurement of growth hormone (GH), plasma was collected on the day of sacrifice every 30min for 3 h. Values for GH represent the
AUC. Data were analysed using unpaired two-tailed Student’s t-test. Values represent means±s.e.m.
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Figure 5 | Food intake after peripheral ghrelin treatment in Gpr83 ko mice. Acute food intake (% to saline treated mice) of chow-fed Gpr83 ko
and wt mice treated with a single intraperitoneal (i.p.) injection of ghrelin (4.8mmol kg 1) or saline (N¼ 5–7 mice per group) (a). Ghrelin induced GH
secretion of chow-fed Gpr83 ko and wt mice following single i.p. treatment with ghrelin (4.8 mmol kg 1, N¼8–17 mice per group) (b). Cumulative
food intake of HFD-fed Gpr83 ko and wt mice treated for 6 days via twice daily subcutaneous injection of either ghrelin (2.4mmol kg 1 per day) or
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Figure 6 | Effects of central ghrelin treatment in Gpr83 ko mice. Body weight (a,b), cumulative food intake (c,d) and change of fat mass (e) of Gpr83 ko
and wt mice treated chronically for 7 days via icv ghrelin infusion (5 nmol per day) in the lateral ventricle (N¼ 6–7 mice per group). *Po0.05;
**Po0.01; ***Po0.001 based on 2-way ANOVA followed by Bonferroni post-hoc test (a–d) or unpaired 2-tailed Student’s t-test (e). 2-way ANOVA p-value
for overall treatment is P¼0.027 (a), P¼0.0047 (b), P¼0.241 (c) and P¼0.0082 (d). Data represent mean±s.e.m.
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chow-fed Gpr83 ko mice, we investigated whether loss of Gpr83
protects against the effects of chronic HFD exposure. Indeed,
after 18 weeks of HFD exposure, body weight remained signi-
ficantly decreased in Gpr83 ko mice compared with wt controls
(Fig. 7a). This decreased body weight was reflected in decreased
body fat, but not in lean tissue mass (Fig. 7b,c). Gpr83 ko mice
further showed an improved glucose tolerance (Fig. 7d) without a
change in insulin sensitivity (Fig. 7e). Surprisingly, however, food
intake was increased in the Gpr83 ko mice compared with that in
wt controls (Fig. 7f–g). Consistent with this effect, expression of
AgRP, Npy, Hcrt and Ghsr1a were increased in the hypothalamus
of the Gpr83 ko mice (Fig. 7h), notably, without any difference in
plasma levels of des-acyl or acyl ghrelin (Fig. 7i). Measurement of
energy metabolism followed by analysis of covariance analysis
(as previously suggested11) further revealed that energy
expenditure is increased in HFD-fed Gpr83 ko mice (Fig. 7j,k),
notably, without changes in locomotor activity (Fig. 7l). No
overall difference was further observed in the respiratory quotient
(RQ), despite significantly increased RQ during the dark phase
(Fig. 7m). Taken together, these data indicate that in addition to
modulating ghrelin action, Gpr83 influences systemic energy
metabolism, particularly in response to HFD exposure.
Heterodimerization of Gpr83 with Mc3r. As our data point to a
more complex role of Gpr83 in systems metabolism, we next
tested the hypothesis that Gpr83 might also interact with other
hypothalamic GPCRs. Accordingly, based on previous reports
indicating that Ghsr1a interacts with the melanocortin 3 receptor
(Mc3r)12, we next analyzed heterodimer formation between
Gpr83 and Mc3r in vitro. Both sandwich ELISA and YFP-PCA
revealed a robust interaction between Gpr83 and Mc3r
(Supplementary Fig. S2A,B). Furthermore, a-melanocyte-
stimulating hormone stimulation of COS-7 cells cotransfected
with Gpr83 and Mc3r led to a two-fold increase in cAMP
accumulation compared with cells transfected with Mc3r alone
(Supplementary Fig. S2C). The same results were observed after
stimulation with the selective Mc3r ligand g-melanocyte-
stimulating hormone (data not shown). Again, these effects
were not due to changes in cell surface or total expression of
Mc3r (Supplementary Fig. S2D,E). These data are consistent with
a more complex role for Gpr83 in the regulation of energy
metabolism and point to its interaction with multiple other
relevant receptors.
Discussion
Previous studies have shown that Gpr83 is widely distributed in
the brain, including hypothalamic nuclei governing energy
balance, thus suggesting a role of Gpr83 in the neuroendocrine
control of energy metabolism. Here we show for the first time that
in the ARC, Gpr83 is colocalized with the ghrelin receptor
(Ghsr1a) and AgRP, and that hypothalamic expression of Gpr83
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Figure 7 | Metabolic phenotype of global Gpr83 ko mice after HFD exposure. Body weight (a), body composition (b,c), glucose tolerance (ipGTT, 1.5 g
glucose per g body weight) (d), insulin sensitivity (ipITT) (e), as well as food intake (f,g) of Gpr83 ko and wt mice fed with a HFD. Hypothalamic expression
pattern of genes related to food intake (h) plasma levels of acyl- and desacyl ghrelin (i), as well as measurement of energy expenditure (j,k), locomotor
activity (l) and RQ (m) in Gpr83 ko and matched wt control mice fed with a HFD. Panels (a–h) and (j–m) and contain N¼ 5–9 mice each genotype,
Panel i contains N¼ 7–16 mice each genotype. Data in panel (h) are normalized to housekeeping gene hypoxanthine phosphoribosyltransferase 1
(HPRT). *Po0.05, **Po0.01, ***Po0.001 based on unpaired two-tailed Student’s t-test (b,d,g,h,k) or two-way analysis of variance followed by Bonferroni
post-hoc test (f). Data represent means±s.e.m.
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analysis further revealed that Gpr83 forms heterodimer with
Ghsr1a and that concomitant overexpression of both receptors
led to an inhibition of the acyl-ghrelin-mediated activation of
Ghsr1a, both in HEK293 cells and in mouse hypothalamic N41
cells. Together, these data indicate that the Gpr83/Ghsr1a
dimerization affects ghrelin’s ability to activate its only known
endogenous receptor.
The functional interaction of Gpr83 and Ghsr1a is further
supported by in vivo analysis showing a superior effect of ghrelin
treatment on body weight, body fat mass and food intake in
Gpr83 ko compared with that of wt mice. However, although our
data strongly indicate a functional interaction of Gpr83 and
Ghsr1a, further analyses are warranted to narrow down the
molecular pathways of Gpr83 signalling. The decreased body
fat mass with decreased plasma concentrations of leptin and
increased levels FFAs observed here in the Gpr83 ko mice
indicate that Gpr83 is also implicated in lipid utilization. The
observation of increased food intake and expression of AgRP,
Npy, Hcrt and Ghsr1a in HFD-fed Gpr83 ko mice is consistent
with our in vitro and in vivo data, indicating that ghrelin
signalling is increased in these ko animals and suggests an
important role of GPCR dimerization for body weight main-
tenance. However, the observed increase in energy metabolism
when Gpr83 ko mice are fed an HFD suggests that additional
Gpr83 signalling mechanisms or other unidentified interactions
could have an important physiological role in the control of
energy metabolism, particularly after HFD exposure. Further-
more, the observation that Gpr83 ko mice are lean, resistant to
diet-induced obesity and -protected from diet-induced glucose
intolerance upon HFD exposure supports a role of Gpr83 in the
regulation of systemic metabolism that is beyond the modulation
of ghrelin action.
Collectively, our data identify Gpr83 as a novel, central
regulator of ghrelin receptor activity and suggest that in addition
to regulating ghrelin signalling, Gpr83 has an important role in
the regulation of systemic energy metabolism. Further analyses
are required to elucidate the different mechanisms through which
Gpr83 exerts these effects, including the specific nature of the
molecular interaction with Ghsr1a and other receptors.
Methods
Generation of receptor constructs. Constructs were amplified and cloned into
the pcDps vector. Haemagglutinin tags were cloned either at the amino terminus
(N-HA) or behind the signal peptide sequence. FLAG-tags were generated at the
carboxy terminus (C-FLAG). The pcDps (NHA-rM3R) was kindly provided by
Torsten Schöneberg (University of Leipzig), the pcDNA3 (MCFD2-YFP1 and
-YFP2) constructs were provided by Hans-Peter Hauri (University of Basel)13.
MC3R was amplified from human genomic DNA and the GHSR from human
complementary DNA (UMR cDNA Resource Center)14,15. Receptor-YFP1
and -YFP2 fusion genes were generated by replacement of the MCFD2 gene.
The pGL4.30 (luc2P/NFAT-RE/Hygro) vector was purchased from Promega.
Measurement of inositol-3 phosphate. Intracellular inositol-3 phosphate was
determined using a luciferase reporter assay (Promega). Receptor DNA (pcDps) and
a reporter construct containing a response element and the firefly luciferase gene
under control of the nuclear factor of activated T cells were cotransfected and cells
were stimulated 2 days after transfection for 6 h at 37 C with human n-octanoyl
ghrelin (C8, AnaSpec), rat (des-octanoyl)-ghrelin (PolyPeptide Laboratories) or
rodent obestatin (PolyPeptide Laboratories), and lysed with 100ml 1 Passive Lysis
Buffer (Promega). Inositol-3 phosphate accumulation was determined by luciferase
activity according to the manufacturer’s instructions.
Receptor dimerization studies. Receptor dimerization was measured using two
independent approaches. For sandwich ELISA, HA- and FLAG-tagged constructs
were cotransfected in COS-7 and N41 cells. For YFP-PCA, receptor-YFP1 and
-YFP2 constructs were cotransfected in HEK293 cells. Cotransfection of MC3R and
GHSR was used as positive control, whereas the respective cotransfection with the
rM3R was used as a negative control.
Cells were collected and solubilized at 4 C (10mM Tris/HCl, pH 7.4, 150mM
NaCl, 1mM EDTA, 1mM dithiothreitol, 1% deoxycholate-Na, 1% NP-40 and
0.2mM phenylmethylsulphonyl fluoride) overnight. Lysates were incubated in
anti-FLAG antibody-coated 96-well plates for 2 h. The HA epitope was probed with
a biotin-labelled antibody. Bound biotin anti-HA antibody was detected using
peroxidase-labelled streptavidin (BioLegend) in a substrate/chromogen reaction
as described elsewhere16. Total protein concentration of lysates was measured
using a bicinchoninic acid-based protein assay (Thermo Scientific).
Interaction between receptor-YFP1 and -YFP2 constructs reconstitutes
the active YFP. A variant of YFP (Q69M) that is characterized by strong
photostablility13 was used. Following collection of the cells, fluorescence
was assessed using flow cytometry.
Cell surface and total expression studies. HA-tagged receptors were transfected
into COS-7 cells using 48-well plates (3.75 104 cells per well). Cells were washed
3 days after transfection, paraformaldehyde-fixed and probed with a biotin-labelled
anti-HA antibody (Roche). Bound biotin anti-HA antibody was detected as
described12. Total receptor expression was measured via sandwich ELISA as
described above, using HA- (N-terminal or behind signal peptide sequence) and
C-FLAG double-tagged constructs.
Generation of global Gpr83 ko mice. Gpr83 ko mice were generated as described
elsewhere17. Briefly, a 2,374 kb genomic region containing exons 2 and 3 of the
Gpr83 isoform 1 (NM_010287) was deleted by mating Gpr83 floxed mice
with mice expressing the cre recombinase under the control of the promine
1 promoter. Genotyping was performed by PCR analysis. Primer 1:
50-TGGAAATGCCACCCCAGAGC-30 ; primer 2: 50-AGACGGAGATGGGA
GCATGC-30 ; and primer 3: 50-TGTGAGCACACACTCCCTGG-30 . Genotyping
was confirmed by quantitative PCR analysis by using primers amplifying a coding
175-bp fragment in exons 2/3, which is excised in the ko mice (Supplementary
Fig. S3).
Ghrelin treatment of Gpr83 ko mice. Mice were housed at an ambient
temperature of 23 C with constant humidity and a 12-h light–dark cycle. Mice had
free access to water and were, if not indicated otherwise, fed ad libitum with either
a regular chow diet (Teklad LM-485) or a HFD (58% kcal fat; Research Diets Inc.,
New Brunswick, USA). All procedures were approved by the Institutional Animal
Care and Use Committee of the University of Cincinnati. Measurements of energy
expenditure were performed using a customized indirect calorimetric system
(TSE Systems Gmbh, Bad Homburg, Germany). After adaptation for 24 h,
recordings were collected over the following 100 h. Body fat and lean tissue mass
was assessed using the EchoMRI (Houston, TX, USA).
Acute food intake was measured in 12-week-old, chow-fed, male Gpr83 ko
(N¼ 14) and wt (N¼ 10) mice, and were treated with a single intraperitoneal
injection of either rat ghrelin (4.8 mmol kg 1) or saline followed by measurement
of food intake at 0, 0.5, 1, 2, 4, 8 and 24 h post injection.
Ghrelin-induced GH secretion was assessed in 9-week-old chow-fed Gpr83 ko
(N¼ 8) and wt control mice (N¼ 17). For analysis of GH, mice were injected with
a single intraperitoneal injection of rat ghrelin (4.8 mmol kg 1) followed by blood
sampling at time points 0, 10 and 20min post injection. Plasma GH levels were
assessed using a commercially available ELISA (Millipore, Billerica, MA, USA).
Effects of peripheral ghrelin treatment were assessed in 24-week-old, and HFD-
fed male Gpr83 ko (N¼ 16) and wt (N¼ 8) mice were treated twice daily for 6
consecutive days via subcutaneous injection of either rat ghrelin (2.4 mmol kg 1
per day) or saline.
Central effects of ghrelin were assessed in 14-week-old, chow-fed, male Gpr83
ko (N¼ 14) and wt (N¼ 12) mice. For icv infusion, rat ghrelin was dissolved in
saline and infused at a dose of 5 nmolper day per mouse using osmotic minipumps
(1007D; Alzet, Cupertino, CA). For icv surgery, mice were anaesthetized using 5%
isoflurane and maintained on 2.5% isoflurane throughout the surgery. Mice were
stereotaxically implanted (David Kopf Instruments, Tujunga, CA) with a cannula
(Brain Infusion Kit No. 3; Alzet) placed in the lateral cerebral ventricle using the
coordinates  0.7mm posterior to bregma,  1.2mm lateral to the midsagittal
suture and to a depth of  2.5mm from the surface of the brain, with bregma and
lambda being horizontal. A polyethylene catheter attaching the cannula to the
minipump was subcutaneously implanted in the interscapular region. The infusion
rate of the pumps was 0.5 ml h 1 for 7 days. Directly after surgery, the animals
received a single subcutaneous injection of 0.28mg kg 1 buprenorphine
(Buprenex; Reckitt Benckiser Healthcare, Richmond, VA). Assessment of body
weight and food intake started the day after the surgery. Body composition (fat and
lean tissue mass) was assessed immediately before surgery and after 7 days.
Colocalization of Gpr83 with Ghsr and AgRP. To check whether Gpr83 is
located in neurons expressing Ghsr or AgRP, in situ hybridization histochemistry
was performed to visualize the gene expression of Gpr83; immunohistochemistry
of b-galactosidase, the products of lacZ gene driven by the Ghsr promoter in Ghsr
ko mice18, was used to visualize the Ghsr. Immunohistochemistry of AgRP neurons
were performed in fasted mouse ARC. Ghsr ko mice or 16-h fasted wt mice were
perfused transcardially with diethylpyrocarbonate-treated 0.9% NaCl followed by
4% 4 C paraformaldehyde. After post-fixation and saturation with 30% sucrose,
brains were cut by cryostat into 25 mm. Sections were treated by 0.1M PBS-
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2968 ARTICLE
NATURE COMMUNICATIONS | 4:1968 | DOI: 10.1038/ncomms2968 | www.nature.com/naturecommunications 7
& 2013 Macmillan Publishers Limited. All rights reserved.
buffered methanol and H2O2 for 10min, 0.2N HCl for 10min, 0.2% glycine
buffer 30 s and 0.1% Triton X-100 for 10min. Brain sections were hybridized in
hybridization buffer (Sigma-Aldrich, USA) containing 100 nM locked nucleic acid
(LNA) – modified cDNA probes labelled with digoxigenin (50-AGAG
AGAAGAAGGTAGCCATGA-30) (Exiqon, Denmark) in 52 C for 8 h. After
stringent washing in SSC buffer in 52 C and final washing in 0.1M PBS, sections
were then coincubated with sheep anti-digoxigenin antibody (1:200, Abcam, USA)
and chicken anti-b-galactosidase (1:200, Abcam) or goat-anti AgRP antibody
(R&D) in 4 C over night. Sections were incubated with biotinylated anti-sheep
secondary antibody for an hour and then incubated with either streptavidin
conjugated with DyLight 488 (1:200, for Gpr83) and donkey anti-chicken antibody
conjugated by Cy3 (1:300, for b-galactosidase), or incubated with streptavidin-
conjugated Cy3 (1:200, for Gpr83) and horse anti-goat antibody conjugated by
DyLight 488 (1:300, for AgRP) (all from Jackson ImmunoResearch Laboratories,
USA). After thorough rinsing, sections were mounted with mounting medium
and visualized by confocal microscopy.
Analysis of plasma samples. Plasma total immunoreactive insulin and leptin
were measured with Multiplex Luminex xMAP assay (Millipore Corporation,
Massachusetts, USA). The lower and upper limits of detection were 68.5 and
50,000 pgml 1, with minimum detectable concentrations of 25 and 22 pgml 1.
Plasma triglycerides and total cholesterol were determined using commercially
available kits from ThermoFisher Scientific Inc. (Virginia, USA). Plasma FFA levels
were determined using kits from Wako Chemical Inc. (Richmond, Virginia, USA),
according to the manufacturer’s instructions. Total IGF-I (mouse high-sensitivity
IGF-I; IDS, Boldon, UK) and GH (Mediagnost, Reutlingen, Germany) were ana-
lysed in plasma samples using commercially available immunoassays, according to
the manufacturer’s instructions. Plasma levels of desacyl and acyl ghrelin were
assessed in 28-week-old Gpr83 ko (N¼ 16) and wt mice (N¼ 7) fed with an HFD
diet for 15 weeks as described previously19.
Data analysis. Analyses were performed using Graph Pad Prism (GraphPad
Software, San Diego, California, USA). Differences between treatment groups were
assessed by two-way analysis of variance followed by Dunnett’s or Bonferroni’s post
hoc test, one-way analysis of variancefollowed by Bonferroni’s or Newman Keuls’
post-hoc test, or unpaired two-tailed Student’s t-test. Data for energy expenditure
were analysed using analysis of covariance by using body mass as a covariate. All
results are given as means±s.e.m. Results were considered statistically significant
when Po0.05, with the significance level indicated as *Po0.05, **Po0.01 and
***Po0.001.
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